EUVIMEDObjevte EUVIMED
Crossref

Exosomes derived from miR‐129‐5p modified bone marrow mesenchymal stem cells represses ventricular remolding of mice with myocardial infarction

Shuo Wang, Jingjie Dong, Liu Li, Rubing Wu, Lei Xu, Yanchun Ren, Xitian Hu

Journal of Tissue Engineering and Regenerative Medicine · 2022-02 · 16 (2) · 177-187

DOI: 10.1002/term.3268 ↗

At a glance

Journal article in Journal of Tissue Engineering and Regenerative Medicine, 2021-12. Written by Shuo Wang and 6 co-authors. Institution: Department of Cardiology, Shijiazhuang People's Hospital, Shijiazhuang, Hebei, China. Major MEDLINE topics: Exosomes, Mesenchymal Stem Cells, MicroRNAs, Myocardial Infarction. Cited 40 times so far (Crossref); 47 references. Funded by: Hebei Provincial Health Commission Youth Science and Technology Project.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Myocardial infraction (MI) is a severe disease with great mortality. Mesenchymal stem cells-derived exosomes display protection against MI. MicroRNA-129-5p was reported to exert anti-inflammation activity by targeting high mobility group box 1 (HMGB1). In the present study, the effects of MSCs derived exosomes overexpressing miR-129-5p on MI were evaluated. Bone marrow mesenchymal stem cells (BMSCs) were transfected with miR-129-5p for exosomes isolation. Myocardial infraction mice model was established and administrated exosomes overexpressing miR-129-5p. The cardiac function, expression of HMGB1, inflammatory cytokines, apoptosis and fibrosis in heart tissues were measured. miR-129-5p inhibited HMGB1 expression in BMSCs. Myocardial infraction mice treated with exosomes overexpressing miR-129-5p had enhanced cardiac function and decreased expression of HMGB1 and production of inflammatory cytokines. Exosomes overexpressing miR-129-5p further prevented apoptosis and fibrosis. Exosome-mediated transfer of miR-129-5p suppressed inflammation in MI mice by targeting HMGB1.

Subjects

MeSH terms (MEDLINE)

ExosomesMesenchymal Stem CellsMicroRNAsMyocardial InfarctionAnimalsApoptosisMiceMyocardium

Author keywords

HMGB1exosomesinflammationmiRNAmyocardial infarction

Substances

MicroRNAs

Authors and institutions

  • Department of Cardiology, Shijiazhuang People's Hospital, Shijiazhuang, Hebei, China.
  • Department of Cardiology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Funding

  • Hebei Provincial Health Commission Youth Science and Technology Project

Cite

APA

Wang, S., Dong, J., Li, L., Wu, R., Xu, L., Ren, Y., & Hu, X. (2022). Exosomes derived from miR‐129‐5p modified bone marrow mesenchymal stem cells represses ventricular remolding of mice with myocardial infarction. Journal of Tissue Engineering and Regenerative Medicine, 16(2), 177-187. https://doi.org/10.1002/term.3268

Vancouver

Wang S, Dong J, Li L, Wu R, Xu L, Ren Y, et al. Exosomes derived from miR‐129‐5p modified bone marrow mesenchymal stem cells represses ventricular remolding of mice with myocardial infarction. Journal of Tissue Engineering and Regenerative Medicine. 2022;16(2):177-187. doi:10.1002/term.3268

BibTeX
@article{Wang2022,
  author = {Wang, Shuo and Dong, Jingjie and Li, Liu and Wu, Rubing and Xu, Lei and Ren, Yanchun and Hu, Xitian},
  title = {Exosomes derived from miR‐129‐5p modified bone marrow mesenchymal stem cells represses ventricular remolding of mice with myocardial infarction},
  journal = {Journal of Tissue Engineering and Regenerative Medicine},
  year = {2022},
  volume = {16},
  number = {2},
  pages = {177--187},
  doi = {10.1002/term.3268}
}
Start for free →